Möchten Sie immer auf dem neuesten Stand bleiben?

Austin, TX, USA, April 02, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Environmental Mass Spectrometry Market Size, Trends and Insights By Product...

Candidate has potential to be a first-in-class treatment offering biologic-like disease control from an oral small moleculeRegulatory submission preparation and entry into the clinic is expected in H1...

GARDian3 trial enrollment and dosing completed (N=63) in less than nine monthsTopline results expected in 2Q27 with BLA to follow by mid-2027OCU410ST represents a potential first-in-class, one-time...

Government Policies and war in the Middle East, delivers jobs shock for the UK's young - and undermines business growth

ZymoChem has demonstrated that its bio-based and biodegradable SAP matches and surpasses the performance of conventional petroleum-based materials.

Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a Phase 3 study in chronic tetraplegia in mid-2026....

4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics,...

GEVORKYAN, a.s. pokračuje v rozširovaní portfólia a prináša nové technologické riešenia pre zákazníkov z úplne rôznych, navzájom neprepojených odvetví európskeho priemyslu. Pre dánsku značku audio...

GEVORKYAN, a.s. pokračuje v rozšiřování portfolia a přináší nová technologická řešení pro zákazníky z naprosto odlišných, vzájemně nepropojených odvětví evropského průmyslu. Pro dánskou značku audio...

GEVORKYAN, a.s. continues to expand its portfolio and brings new technological solutions for customers from completely different, mutually unrelated sectors of European industry. For a Danish audio...